• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of new or reformulated infant formula notification reviews completed during the month within 90 days of filing

Dictionary: Timely review of notifications for new and reformulated infant formulas is essential for protecting the health and well being of infants. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of September 30, 2013.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 201390100
Nov 201390100
Dec 201390100
Jan 201490TBD
Feb 201490TBD
Mar 201490TBD
Apr 201490TBD
May 201490TBD
Jun 201490TBD
Jul 201490TBD
Aug 201490TBD
Sep 201490TBD

FY 2014 YTD: 100%

Number of new or reformulated infant formula notification reviews due to be completed during the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A1
Nov 2013N/A2
Dec 2013N/A4
Jan 2014N/ATBD
Feb 2014N/ATBD
Mar 2014N/ATBD
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 7

Number of infant formula notification reviews completed during the month within 90 days of filing

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A1
Nov 2013N/A2
Dec 2013N/A4
Jan 2014N/ATBD
Feb 2014N/ATBD
Mar 2014N/ATBD
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 7

Total number of infant formula notification reviews completed during the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A1
Nov 2013N/A2
Dec 2013N/A4
Jan 2014N/ATBD
Feb 2014N/ATBD
Mar 2014N/ATBD
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 7

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.